April 2016 – Page 4 – Policy & Medicine

FDA: Biosimilars Labeling Guidance

Update on Biosimilars US Regulation 1st Quarter 2016

MedPAC Meeting on Part B Drug Payment Policy

2015 Front Line of Healthcare Report – CME and Conferences are a More Frequently Utilized Source of Information

ABIM Considers Open Book Testing

Courts to Finally Take Up CMS Recovery Audit Contractors Appeals Backlog

Streebo Spin’s Off Life Science Business as qordata

Specialty Pricing Drugs: How Did We Get Here and Where Do We Go

Massachusetts Medical Society Requires Social Media Disclosure by Physicians